AMBULAPSENCT03764852
AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 24 words Show 7 more changesShow less
- Trial completed
- Final enrollment: 55 participants (planned 80)
- Primary completion date changed from estimate of Sep 2026 to Apr 28, 2026
- Secondary endpoints: details revised at 1 of 1 entry
- Study description revised
- Site details revised at 5 of 5 sites
- Publications: details revised at 4 of 4 entries
- Notable Primary completion date: Sep 2024 to Sep 2026
- Study completion date: Dec 2024 to Dec 2026
- Notable Primary completion date: Jan 2021 to Sep 2024
- Study completion date: Jan 2021 to Dec 2024
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary completion date: Jan 2019 to Jan 2021
- Start date changed from estimate of Jan 2019 to Dec 14, 2019
- Site details revised at 5 of 5 sites
- Minor Interventions: outpatient laparoscopic (Other) to outpatient laparoscopic (Procedure), outpatient laparoscopic (Procedure)
- Study description expanded, about 2 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Successful outpatient treatment
Timeframe: 24 hours after surgery
Secondary (1)
The percentage of failure of the outpatient
Arms and interventions
outpatient laparoscopicExperimental
Patients will have laparoscopic outpatients. The procedure is identical to that performed in hospital. What changes is that the patient will return home at night if her condition allows it.
Procedures: outpatient laparoscopic
Sites
5 sites in 1 country